ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

Open Ended Schemes(Equity Scheme - Sectoral/ Thematic)Very High RiskISIN INF00XX01BL5

NAV · 06-Jul-2026

₹17.6285

+7.58%

+11.82%

1Y (CAGR)

+6.24%

3Y (CAGR)

+19.83%

5Y (CAGR)

—

Since inception (CAGR)

+12.98%

NAV history

hover for values

Risk & SIP analytics

Q1 · TOP · 3Y in category

Volatility (3y)

14.17%

Downside dev (3y)

10.41%

Max drawdown (3y)

-17.6%

Sharpe (3y)

0.94

SIP XIRR (3y)

+12.94%

Calendar-year returns

2022 -8.7%2023 +31.6%2024 +41.3%2025 -10.0%

Fund facts

Fund managerNilay Dalal · Animesh Singh

AUM₹2,379 Cr

TER · AMFI officialDirect 0.95% · Regular 2.66% (2026-06-30)

Launch date18-Oct-2021

Plan typeOpen Ended · Equity

Min lumpsumRs. 5000/- and in multiples of Rs. 1/- thereafter

Lock-inNone

Volatility13.60

AMCITI Asset Management Limited

Objective · The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

scheme documents ↗